HomeCompareFOSYF vs JNJ

FOSYF vs JNJ: Dividend Comparison 2026

FOSYF yields 750.08% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FOSYF wins by $1613861.23M in total portfolio value
10 years
FOSYF
FOSYF
● Live price
750.08%
Share price
$0.27
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1613861.26M
Annual income
$1,278,548,374,466.99
Full FOSYF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — FOSYF vs JNJ

📍 FOSYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFOSYFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FOSYF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FOSYF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FOSYF
Annual income on $10K today (after 15% tax)
$63,756.38/yr
After 10yr DRIP, annual income (after tax)
$1,086,766,118,296.94/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, FOSYF beats the other by $1,086,766,114,310.95/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FOSYF + JNJ for your $10,000?

FOSYF: 50%JNJ: 50%
100% JNJ50/50100% FOSYF
Portfolio after 10yr
$806930.65M
Annual income
$639,274,189,578.19/yr
Blended yield
79.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FOSYF
No analyst data
Altman Z
126.0
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FOSYF buys
0
JNJ buys
0
No recent congressional trades found for FOSYF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFOSYFJNJ
Forward yield750.08%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$1613861.26M$30.3K
Annual income after 10y$1,278,548,374,466.99$4,689.40
Total dividends collected$1587049.20M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FOSYF vs JNJ ($10,000, DRIP)

YearFOSYF PortfolioFOSYF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$85,708$75,007.50$10,592$272.30+$75.1KFOSYF
2$692,521$600,813.59$11,289$357.73+$681.2KFOSYF
3$5,278,008$4,537,011.15$12,123$472.89+$5.27MFOSYF
4$37,963,902$32,316,433.39$13,141$629.86+$37.95MFOSYF
5$257,861,693$217,240,318.07$14,408$846.81+$257.85MFOSYF
6$1,654,938,592$1,379,026,579.77$16,021$1,151.60+$1654.92MFOSYF
7$10,042,277,404$8,271,493,110.41$18,122$1,588.22+$10042.26MFOSYF
8$57,653,620,118$46,908,383,295.74$20,930$2,228.20+$57653.60MFOSYF
9$313,376,530,888$251,687,157,362.23$24,792$3,191.91+$313376.51MFOSYF
10$1,613,861,262,517$1,278,548,374,466.99$30,274$4,689.40+$1613861.23MFOSYF

FOSYF vs JNJ: Complete Analysis 2026

FOSYFStock

Forsys Metals Corp., an exploration stage company, engages in the acquisition, exploration, and development of mineral properties in Namibia, Africa. The company explores for uranium and gold mineral properties. Its flagship project is Norasa Uranium Project, which includes the Valencia project covering an area of 735.6 hectares located in the south-west of the town of Usakos in central-west Namibia; and the Namibplaas project located in the northeast of Valencia. The company was formerly known as Forsys Technologies Inc. and changed its name to Forsys Metals Corp. in June 2005. Forsys Metals Corp. was incorporated in 1985 and is headquartered in Toronto, Canada.

Full FOSYF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this FOSYF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FOSYF vs SCHDFOSYF vs JEPIFOSYF vs OFOSYF vs KOFOSYF vs MAINFOSYF vs ABBVFOSYF vs MRKFOSYF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.